ELVElevance Health
What is the market doing?
The market is with it: in an uptrend and insiders net buying.
In an uptrend, above its rising 50- and 200-day averages. Price is +14% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 8, 2026.
Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 2.7% since the previous count, down from 2.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ELV is trading
Elevance Health is +33% over the past year while the S&P 500 is +18%: 14 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +14%
vs 200-day average · a clear uptrend
- RSI (14)
- 53
RSI (14) · neutral
- Below its 52-week high
- 4.0%
Below its 52-week high
Details›
- Last close2026-10-09
- $412.79
- 1 monthS&P 500 +2.7%
- −0.89%
- 1 yearS&P 500 +18%
- +33%
- 5 yearsS&P 500 +88%
- +20%
- vs 50-day average$399.37
- +3.4%
- 52-week high
- $430.21
- 52-week low
- $277.89
- Annualised volatility
- 36%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $542K
| Year | Return |
|---|---|
| 2026 (year to date) | +19% |
| 2025 | −3.1% |
| 2024 | −21% |
| 2023 | −6.9% |
| 2022 | +12% |
| 2021 | +46% |
| 2020 | +7.7% |
| 2019 | +16% |
| 2018 | +18% |
| 2017 | +59% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +1.6% |
| Feb | 10 | 5 of 10 | −0.90% |
| Mar | 10 | 5 of 10 | +1.1% |
| Apr | 10 | 8 of 10 | +6.7% |
| May | 10 | 7 of 10 | +0.64% |
| Jun | 10 | 5 of 10 | −0.57% |
| Jul | 11 | 6 of 11 | −0.84% |
| Aug | 11 | 7 of 11 | +0.80% |
| Sep | 11 | 3 of 11 | −2.1% |
| Oct | 11 | 8 of 11 | +4.0% |
| Nov | 10 | 8 of 10 | +6.0% |
| Dec | 10 | 5 of 10 | +0.12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Healthcare
Ranks #17 of 446 by RyuScore